Principal Financial Group
DARE icon

Principal Financial Group’s Dare Bioscience DARE Stock Holding History

Principal Financial Group’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,976
Closed -$757K – 2173
2016
Q2 		$757K Sell
2,976
-72
-2% -$23K ﹤0.01% 1794
2016
Q1 		$991K Hold
3,048
– – ﹤0.01% 1732
2015
Q4 		$1.02M Hold
3,048
– – ﹤0.01% 1756
2015
Q3 		$1.34M Buy
3,048
+22
+0.7% +$11.1K ﹤0.01% 1730
2015
Q2 		$1.67M Buy
3,026
+560
+23% +$385K ﹤0.01% 1718
2015
Q1 		$2.67M Buy
2,466
+6
+0.2% +$5.81K ﹤0.01% 1592
2014
Q4 		$1.84M Buy
2,460
+12
+0.5% +$7.49K ﹤0.01% 1700
2014
Q3 		$1.24M Buy
2,448
+31
+1% +$16.5K ﹤0.01% 1737
2014
Q2 		$1.68M Buy
+2,417
New +$1.87M ﹤0.01% 1718

Other funds holding DARE

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Financial Group's DARE Position: Q3 2016 in Review

Principal Financial Group sold out of Dare Bioscience (DARE) in Q3 2016, closing a stake of 2,976 shares — an estimated $757K sold.

Principal Financial Group first reported a position in DARE in Q2 2014 and held it in 9 quarters. The position peaked at $2.67M in Q1 2015. 31 funds tracked by Wall St. Rank hold DARE as of Q3 2016.

  • Principal Financial Group reported no remaining Dare Bioscience position as of Q3 2016 after selling out during the quarter.
  • Principal Financial Group sold 2,976 Dare Bioscience shares in Q3 2016, an estimated $757K.
  • Principal Financial Group first reported a position in Dare Bioscience in Q2 2014 and held it in 9 quarters.
  • Principal Financial Group's Dare Bioscience position peaked at $2.67M in Q1 2015.
  • 31 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2016.

Based on Principal Financial Group's 13F filing for Q3 2016, filed 10 Nov 2016.